Growth Opportunities in the Western European IVD Industry, Forecast to 2021

Growth Opportunities in the Western European IVD Industry, Forecast to 2021

Increased R&D Investments and M&As Propel the Growth of Mobile POCT and Clinical Genomics Solutions

RELEASE DATE
23-Jun-2017
REGION
Europe
Research Code: MD00-01-00-00-00
SKU: HC02835-EU-MR_20306

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02835-EU-MR_20306

$4,950.00

$3,712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

Despite global economic and industry challenges, in-vitro diagnostics (IVD) markets continue to grow, mainly due to fast-growing segments like molecular diagnostics, point-of-care testing (POCT), and tissue diagnostics.. A few market dynamics are either positively or negatively affecting certain specific segments in the IVD space; for example, the self-monitoring blood glucose (SMBG) segment's growth in emerging markets is severely dampened by the slowing growth from reimbursement reductions in Western Europe.The broad applicability of POCT, combined with downward pricing trends enabled by microfluidics integration, supports the long-term growth of this segment. The Western European markets continue to drive molecular diagnostics segment growth rather than the emerging Eastern European markets.

The recent success of companion diagnostic tests and personalised medicine is driving the uptake of various tests in an aim to save costs, thus opening up an opportunity to expand the test menus in existing installs. Diagnostic testing will continue to move towards process simplicity and decentralisation. IVD market participants are expected to employ a diverse set of strategies rather than rely on comprehensive product portfolios to grow their businesses. Companies are also gaining new market access through acquisitions, and this has intensified competition among tier 1 participants.

This study offers comprehensive information on every aspect of the IVD market. It is segmented into 8 subdivisions, namely, immunochemistry, POCT, SMBG, molecular diagnostics, clinical microbiology, haemostasis, hematology, and tissue diagnostics. Discussion on key trends and opportunities and company profile analysis by segment are also provided. In addition, there are dedicated country chapters for the key Western European markets (Germany, France, the United Kingdom, Spain, Italy, Benelux, and Scandinavia) and a snapshot of the regulatory policies awaiting to transform the industry.

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Western European IVD Market Dynamics

Key Trends Driving the Market

Strategic Imperatives for IVD Companies

8 Big Market Directions

Scope and Segmentation

Market Definition—Diagnostics for Health

IVD Value Chain across Patient Continuum

Segment Overview

How Do IVDs Reach Patients in Europe?

Major Regulatory Developments and Future Implications

Reimbursement Policies for IVD across Western Europe (EU5)

Stepping Stones that Promote IVD among the Public (with Government Backing)

Key Trend 1—Consolidation of Labs

Key Trend 2—Decentralized Laboratory Testing

Emerging Technology 1—Companion Diagnostics

Participants are Expanding Their Product Portfolios to Include Companion Diagnostics

Emerging Technology 2—Liquid Biopsy

Participants are Expanding Their Product Portfolios to Include Liquid Biopsy

Other Key Emerging Technologies

Regional Perspective

Market Analysis—Germany

Market Analysis—France

Market Analysis—Italy

Market Analysis—The United Kingdom

Market Analysis—Spain

Market Analysis—Benelux

Market Analysis—Scandinavia

Market Analysis—Rest of Europe

Market Analysis—Rest of Europe (Poland)

Market Drivers

Market Restraints

Growth Opportunity 1—Infectious Disease Diagnostics

Growth Opportunity 2—Data-driven Digital POCT

Growth Opportunity 3—Personalized Medicine through Companion Diagnostics and Pharmacogenomics

Growth Opportunity 4—Genetic Testing

Growth Opportunity 5—Geographical Expansion to Eastern Europe

Western European IVD Market by Segment

Western European IVD Market by Country

Western European IVD Market by Market Participants

Key Mergers, Acquisitions, and Partnership Assessment

Western European IVD Market—Revenue Forecast

Western European IVD Market—Segment Life Cycle Analysis

Segment Overview

Revenue Forecast

Snapshot of Key Participants

Market Share of Top Competitors

Key Trends

Growth Opportunities

Segment Overview

Revenue Forecast

Snapshot of Key Participants

Market Share of Top Competitors

Key Trends

Growth Opportunities

Segment Overview

Revenue Forecast

Snapshot of Key Participants

Market Share of Top Competitors

Key Trends

Growth Opportunities

Segment Overview

Revenue Forecast

Snapshot of Key Participants

Market Share of Top Competitors

Key Trends

Growth Opportunities

Segment Overview

Revenue Forecast

Snapshot of Key Participants

Market Share of Top Competitors

Key Trends

Growth Opportunities

Segment Overview

Revenue Forecast

Snapshot of Key Participants

Market Share of Top Competitors

6Key Trends

Growth Opportunities

Segment Overview

Revenue Forecast

Snapshot of Key Participants

Market Share of Top Competitors

Key Trends

Growth Opportunities

Segment Overview

Revenue Forecast

Snapshot of Key Participants

Market Share of Top Competitors

Key Trends

Growth Opportunities

Top Predictions for the Western European IVD Market

Legal Disclaimer

List of Figures
  • 1. IVD Market: Reimbursement Scenario, Western Europe, 2016
  • 2. IVD Market: Healthcare Structure, Western Europe, 2016
  • 3. IVD Market: Key Drivers, Western Europe, 2017–2021
  • 4. IVD Market: Key Restraints, Western Europe, 2017–2021
  • 5. IVD Market: Key M&A and Partnership Assessment, Western Europe, 2016
  • 6. Immunochemistry Segment: Key Participants, Western Europe, 2016
  • 7. Immunochemistry Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
  • 8. Molecular Diagnostics Segment: Key Participants, Western Europe, 2016
  • 9. Molecular Diagnostics Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
  • 10. POCT Segment: Key Participants, Western Europe, 2016
  • 11. POCT Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
  • 12. Tissue Diagnostics Segment: Key Participants, Western Europe, 2016
  • 13. Tissue Diagnostics Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
  • 14. SMBG Segment: Key Participants, Western Europe, 2016
  • 15. SMBG Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
  • 16. Clinical Microbiology Segment: Key Participants, Western Europe, 2016
  • 17. Clinical Microbiology Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
  • 18. Haemostasis Segment: Key Participants, Western Europe, 2016
  • 19. Haematology Segment: Key Participants, Western Europe, 2016
  • 20. Haematology Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
List of Charts
  • 1. IVD Market: Technology Adoption, Western Europe, 2016
  • 2. IVD Market: Percent Revenue Breakdown by Segment, Western Europe, 2016
  • 3. IVD Market: Percent Revenue Breakdown by Country, Western Europe, 2016
  • 4. IVD Market: Percent Revenue Breakdown, Western Europe, 2016
  • 5. IVD Market: Revenue Forecast, Western Europe, 2016–2021
  • 6. IVD Market: Segment Life Cycle Analysis, Western Europe, 2016
  • 7. Immunochemistry Segment: Revenue Forecast, Western Europe, 2016–2021
  • 8. Immunochemistry Segment: Percent Revenue Breakdown, Western Europe, 2016
  • 9. Molecular Diagnostics Segment: Revenue Forecast, Western Europe, 2016–2021
  • 10. Molecular Diagnostics Segment: Percent Revenue Breakdown, Western Europe, 2016
  • 11. POCT Segment: Revenue Forecast, Western Europe, 2016–2021
  • 12. POCT Segment: Percent Revenue Breakdown, Western Europe, 2016
  • 13. Tissue Diagnostics Segment: Revenue Forecast, Western Europe, 2016–2021
  • 14. Tissue Diagnostics Segment: Percent Revenue Breakdown, Western Europe, 2016
  • 15. SMBG Segment: Revenue Forecast, Western Europe, 2016–2021
  • 16. SMBG Segment: Percent Revenue Breakdown, Western Europe, 2016
  • 17. Clinical Microbiology Segment: Revenue Forecast, Western Europe, 2016–2021
  • 18. Clinical Microbiology Segment: Percent Revenue Breakdown, Western Europe, 2016
  • 19. Haemostasis Segment: Revenue Forecast, Western Europe, 2016–2021
  • 20. Haemostasis Segment: Percent Revenue Breakdown, Western Europe, 2016
  • 21. Haemostasis Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
  • 22. Haematology Segment: Revenue Forecast, Western Europe, 2016–2021
  • 23. Haematology Market: Percent Revenue Breakdown, Western Europe, 2016
Related Research
Despite global economic and industry challenges, in-vitro diagnostics (IVD) markets continue to grow, mainly due to fast-growing segments like molecular diagnostics, point-of-care testing (POCT), and tissue diagnostics.. A few market dynamics are either positively or negatively affecting certain specific segments in the IVD space; for example, the self-monitoring blood glucose (SMBG) segment's growth in emerging markets is severely dampened by the slowing growth from reimbursement reductions in Western Europe.The broad applicability of POCT, combined with downward pricing trends enabled by microfluidics integration, supports the long-term growth of this segment. The Western European markets continue to drive molecular diagnostics segment growth rather than the emerging Eastern European markets. The recent success of companion diagnostic tests and personalised medicine is driving the uptake of various tests in an aim to save costs, thus opening up an opportunity to expand the test menus in existing installs. Diagnostic testing will continue to move towards process simplicity and decentralisation. IVD market participants are expected to employ a diverse set of strategies rather than rely on comprehensive product portfolios to grow their businesses. Companies are also gaining new market access through acquisitions, and this has intensified competition among tier 1 participants. This study offers comprehensive information on every aspect of the IVD market. It is segmented into 8 subdivisions, namely, immunochemistry, POCT, SMBG, molecular diagnostics, clinical microbiology, haemostasis, hematology, and tissue diagnostics. Discussion on key trends and opportunities and company profile analysis by segment are also provided. In addition, there are dedicated country chapters for the key Western European markets (Germany, France, the United Kingdom, Spain, Italy, Benelux, and Scandinavia) and a snapshot of the regulatory policies awaiting to transform the industry.
More Information
No Index No
Podcast No
Table of Contents | Executive Summary~ || Western European IVD Market Dynamics~ || Key Trends Driving the Market~ || Strategic Imperatives for IVD Companies~ || 8 Big Market Directions~ || Scope and Segmentation~ | Market Overview~ || Market Definition—Diagnostics for Health~ || IVD Value Chain across Patient Continuum~ || Segment Overview~ | Market Dynamics—Western Europe~ || How Do IVDs Reach Patients in Europe?~ || Major Regulatory Developments and Future Implications~ || Reimbursement Policies for IVD across Western Europe (EU5)~ || Stepping Stones that Promote IVD among the Public (with Government Backing)~ | Trend Analysis—Western European IVD Market~ || Key Trend 1—Consolidation of Labs~ || Key Trend 2—Decentralized Laboratory Testing~ | Emerging Technologies in the Western European IVD Market~ || Emerging Technology 1—Companion Diagnostics~ || Participants are Expanding Their Product Portfolios to Include Companion Diagnostics~ || Emerging Technology 2—Liquid Biopsy~ || Participants are Expanding Their Product Portfolios to Include Liquid Biopsy~ || Other Key Emerging Technologies~ | Regional Analysis—Western Europe~ || Regional Perspective~ || Market Analysis—Germany~ || Market Analysis—France~ || Market Analysis—Italy~ || Market Analysis—The United Kingdom~ || Market Analysis—Spain~ || Market Analysis—Benelux~ || Market Analysis—Scandinavia~ || Market Analysis—Rest of Europe~ || Market Analysis—Rest of Europe (Poland)~ | Drivers and Restraints—IVD Market~ || Market Drivers~ || Market Restraints~ | Growth Opportunities and Companies to Action~ || Growth Opportunity 1—Infectious Disease Diagnostics~ || Growth Opportunity 2—Data-driven Digital POCT~ || Growth Opportunity 3—Personalized Medicine through Companion Diagnostics and Pharmacogenomics~ || Growth Opportunity 4—Genetic Testing~ || Growth Opportunity 5—Geographical Expansion to Eastern Europe~ | Revenue Forecast—IVD Market~ || Western European IVD Market by Segment~ || Western European IVD Market by Country~ || Western European IVD Market by Market Participants~ || Key Mergers, Acquisitions, and Partnership Assessment~ || Western European IVD Market—Revenue Forecast~ | Segment Analysis—IVD Market~ || Western European IVD Market—Segment Life Cycle Analysis~ | Immunochemistry Segment Analysis~ || Segment Overview~ || Revenue Forecast~ || Snapshot of Key Participants~ || Market Share of Top Competitors~ || Key Trends~ || Growth Opportunities~ | Molecular Diagnostics Segment Analysis~ || Segment Overview~ || Revenue Forecast~ || Snapshot of Key Participants~ || Market Share of Top Competitors~ || Key Trends~ || Growth Opportunities~ | POCT Segment Analysis~ || Segment Overview~ || Revenue Forecast~ || Snapshot of Key Participants~ || Market Share of Top Competitors~ || Key Trends~ || Growth Opportunities~ | Tissue Diagnostics Segment Analysis~ || Segment Overview~ || Revenue Forecast~ || Snapshot of Key Participants~ || Market Share of Top Competitors~ || Key Trends~ || Growth Opportunities~ | Self-monitoring Blood Glucose Segment Analysis~ || Segment Overview~ || Revenue Forecast~ || Snapshot of Key Participants~ || Market Share of Top Competitors~ || Key Trends~ || Growth Opportunities~ | Clinical Microbiology Segment Analysis~ || Segment Overview~ || Revenue Forecast~ || Snapshot of Key Participants~ || Market Share of Top Competitors~ || 6Key Trends~ || Growth Opportunities~ | Haemostasis Segment Analysis~ || Segment Overview~ || Revenue Forecast~ || Snapshot of Key Participants~ || Market Share of Top Competitors~ || Key Trends~ || Growth Opportunities~ | Haematology Segment Analysis~ || Segment Overview~ || Revenue Forecast~ || Snapshot of Key Participants~ || Market Share of Top Competitors~ || Key Trends~ || Growth Opportunities~ | Conclusion~ || Top Predictions for the Western European IVD Market~ || Legal Disclaimer~ | The Frost & Sullivan Story~
List of Charts and Figures 1. IVD Market: Reimbursement Scenario, Western Europe, 2016~ 2. IVD Market: Healthcare Structure, Western Europe, 2016~ 3. IVD Market: Key Drivers, Western Europe, 2017–2021~ 4. IVD Market: Key Restraints, Western Europe, 2017–2021~ 5. IVD Market: Key M&A and Partnership Assessment, Western Europe, 2016~ 6. Immunochemistry Segment: Key Participants, Western Europe, 2016~ 7. Immunochemistry Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021~ 8. Molecular Diagnostics Segment: Key Participants, Western Europe, 2016~ 9. Molecular Diagnostics Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021~ 10. POCT Segment: Key Participants, Western Europe, 2016~ 11. POCT Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021~ 12. Tissue Diagnostics Segment: Key Participants, Western Europe, 2016~ 13. Tissue Diagnostics Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021~ 14. SMBG Segment: Key Participants, Western Europe, 2016~ 15. SMBG Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021~ 16. Clinical Microbiology Segment: Key Participants, Western Europe, 2016~ 17. Clinical Microbiology Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021~ 18. Haemostasis Segment: Key Participants, Western Europe, 2016~ 19. Haematology Segment: Key Participants, Western Europe, 2016~ 20. Haematology Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021~| 1. IVD Market: Technology Adoption, Western Europe, 2016~ 2. IVD Market: Percent Revenue Breakdown by Segment, Western Europe, 2016~ 3. IVD Market: Percent Revenue Breakdown by Country, Western Europe, 2016~ 4. IVD Market: Percent Revenue Breakdown, Western Europe, 2016~ 5. IVD Market: Revenue Forecast, Western Europe, 2016–2021~ 6. IVD Market: Segment Life Cycle Analysis, Western Europe, 2016~ 7. Immunochemistry Segment: Revenue Forecast, Western Europe, 2016–2021~ 8. Immunochemistry Segment: Percent Revenue Breakdown, Western Europe, 2016 ~ 9. Molecular Diagnostics Segment: Revenue Forecast, Western Europe, 2016–2021~ 10. Molecular Diagnostics Segment: Percent Revenue Breakdown, Western Europe, 2016 ~ 11. POCT Segment: Revenue Forecast, Western Europe, 2016–2021~ 12. POCT Segment: Percent Revenue Breakdown, Western Europe, 2016 ~ 13. Tissue Diagnostics Segment: Revenue Forecast, Western Europe, 2016–2021~ 14. Tissue Diagnostics Segment: Percent Revenue Breakdown, Western Europe, 2016 ~ 15. SMBG Segment: Revenue Forecast, Western Europe, 2016–2021~ 16. SMBG Segment: Percent Revenue Breakdown, Western Europe, 2016 ~ 17. Clinical Microbiology Segment: Revenue Forecast, Western Europe, 2016–2021~ 18. Clinical Microbiology Segment: Percent Revenue Breakdown, Western Europe, 2016 ~ 19. Haemostasis Segment: Revenue Forecast, Western Europe, 2016–2021~ 20. Haemostasis Segment: Percent Revenue Breakdown, Western Europe, 2016 ~ 21. Haemostasis Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021~ 22. Haematology Segment: Revenue Forecast, Western Europe, 2016–2021~ 23. Haematology Market: Percent Revenue Breakdown, Western Europe, 2016 ~
Author Saravanan Thangaraj
Industries Healthcare
WIP Number MD00-01-00-00-00
Is Prebook No